Jove
Visualize
Contact Us

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct effects of disease-associated mutations in the proximal C-linker on negatively cooperative binding of cyclic nucleotides to the human HCN4 channel.

Biochemistry and cell biology = Biochimie et biologie cellulaire·2026
Same author

Shifting pain phenotypes with physical therapy treatment: an exploration study.

The Journal of manual & manipulative therapy·2026
Same author

Myasthenia Gravis and Thymectomy at a Tertiary-Care Surgical Centre: A 20-Year Retrospective Review.

Current oncology (Toronto, Ont.)·2025
Same author

How does personal utility depend on clinical setting? Evidence from 3 cohorts.

Genetics in medicine open·2025
Same author

Reproductive carrier screening for genetic disorders: position statement of the Canadian College of Medical Geneticists.

Journal of medical genetics·2025
Same author

Handling Risky Situations, Especially the Unexpected, With Elite Performance.

Journal of the Pediatric Orthopaedic Society of North America·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

A novel KCNA1 mutation associated with global delay and persistent cerebellar dysfunction.

Michelle K Demos1, Vincenzo Macri, Kevin Farrell

  • 1Department of Pediatric Neurology, British Columbia's Children's Hospital, Vancouver, British Columbia, Canada. mdemos@cw.bc.ca

Movement Disorders : Official Journal of the Movement Disorder Society
|February 11, 2009
PubMed
Summary

Episodic Ataxia Type 1, linked to KCNA1 gene mutations, can present with broader symptoms than previously known. This study identifies a new mutation causing persistent cerebellar issues and cognitive delay in a family.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: Jun 25, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

  • Neurogenetics
  • Channelopathies
  • Autosomal dominant disorders

Background:

  • Episodic Ataxia Type 1 (EA1) is an autosomal dominant disorder.
  • EA1 is typically characterized by ataxia and myokymia, linked to KCNA1 gene mutations.
  • The full clinical spectrum of EA1 is not completely understood.

Purpose of the Study:

  • To investigate a family with atypical clinical manifestations of Episodic Ataxia Type 1.
  • To identify the genetic basis of the observed novel phenotype.
  • To understand the functional consequences of the identified mutation.

Main Methods:

  • Clinical evaluation of affected family members.
  • Genetic analysis to identify mutations in the KCNA1 gene.
  • In vitro electrophysiological studies to assess channel function.

Main Results:

  • A novel KCNA1 mutation (c.1222G>T, p.Val408Leu) was identified in affected individuals.
  • Affected individuals exhibited persistent cerebellar dysfunction, cerebellar atrophy, cognitive delay, myokymia, and epilepsy.
  • The p.Val408Leu mutation was found to enhance potassium channel inactivation.
  • Only one individual experienced episodic vertigo.

Conclusions:

  • KCNA1 mutations can lead to a broader clinical phenotype in Episodic Ataxia Type 1.
  • The identified mutation contributes to persistent cerebellar dysfunction and cognitive delay.
  • Understanding the expanded phenotype is crucial for accurate diagnosis and management of EA1.